Treatment of Acute Seizures
For acute seizures, benzodiazepines are first-line treatment, followed immediately by second-line agents (levetiracetam, fosphenytoin, or valproate) if seizures persist beyond 5 minutes or after optimal benzodiazepine dosing.
First-Line Treatment: Benzodiazepines
Benzodiazepines must be administered for any seizure lasting ≥5 minutes 1, 2, 3. The specific agent matters less than rapid administration:
Recommended benzodiazepines:
- Midazolam (intramuscular, buccal, or intranasal): Most versatile for prehospital/emergency settings 3
- Lorazepam (intravenous): 4 mg IV, may repeat once 1, 3
- Diazepam (intravenous or rectal): 10 mg IV or 20 mg rectal 1, 3
Key point: Non-IV routes (buccal/intranasal midazolam) achieve similar seizure cessation rates as IV benzodiazepines but avoid delays from establishing IV access 4. Lorazepam causes less respiratory depression than diazepam (RR 0.72,95% CI 0.55-0.93) 4.
Second-Line Treatment: After Benzodiazepine Failure
If seizures continue after optimal benzodiazepine dosing, immediately administer a second-line agent 1, 2. The 2024 ACEP guidelines provide Level A evidence that fosphenytoin, levetiracetam, or valproate have equivalent efficacy (~45-47% seizure cessation) 2.
Recommended Second-Line Agents (Choose One):
Levetiracetam: 30-50 mg/kg IV at 100 mg/min 1
- Advantages: Minimal hypotension/respiratory depression, no cardiac monitoring required
- Adverse effects: Nausea, rash (rare)
- Best for: Patients with cardiac disease, elderly, or when rapid infusion needed
Valproate: 20-30 mg/kg IV at 40 mg/min 1
- Advantages: Can be given faster than phenytoin with fewer adverse effects; 79% efficacy vs 25% for phenytoin as second-line (NNT 1.9) 1
- Adverse effects: Thrombocytopenia, liver toxicity, hyperammonemia
- Contraindications: Pregnancy, known liver disease
Fosphenytoin: 18-20 PE/kg IV 1, 2
- Advantages: Traditional standard; extensive experience
- Adverse effects: Hypotension (12% vs 0% with valproate), cardiac dysrhythmias, requires cardiac monitoring 1
- Disadvantages: Slower infusion rate, more adverse effects than alternatives
Critical timing: The ESETT trial (Class I evidence) demonstrated no superiority among these three agents, with 45-47% achieving seizure cessation at 60 minutes 2. Choose based on patient-specific factors rather than perceived efficacy differences.
Refractory Status Epilepticus (Third-Line)
If seizures persist after benzodiazepines plus one second-line agent:
Consider these agents 1:
- Propofol: 2 mg/kg bolus, may repeat in 3-5 min; maintenance 5 mg/kg/h (requires intubation) 1
- Midazolam infusion: For intubated patients 3
- Phenobarbital: 10-20 mg/kg; may repeat 5-10 mg/kg at 10 min (high risk of hypotension/respiratory depression) 1
Common pitfall: Propofol is effective (as good as pentobarbital) but requires mechanical ventilation and causes less hypotension than barbiturates (42% vs 77%) 1. Use only in intubated patients without hypotension 1.
Simultaneous Actions During Treatment
While administering anticonvulsants, immediately evaluate for reversible causes 1:
- Hypoglycemia (check fingerstick glucose)
- Hyponatremia (obtain electrolytes)
- Hypoxia (ensure adequate oxygenation)
- Drug toxicity or withdrawal
- CNS infection (consider lumbar puncture if indicated)
- Intracranial hemorrhage or stroke (obtain neuroimaging)
Post-Cardiac Arrest Seizures
For seizures after cardiac arrest, treat with levetiracetam and/or valproate 5. Avoid phenytoin due to negative inotropic and vasodilating effects in this population 5. Consider propofol or benzodiazepines for myoclonus suppression 5.
Special Populations
Neonates: Phenobarbital remains first-line; phenytoin or levetiracetam for second-line 6. Consider sodium channel blockers if channelopathy suspected 6.
Avoid prophylactic antiseizure medications in patients without active seizures—no evidence supports this practice and increases adverse event risk 7, 8.
Critical Timing Principles
- Administer first benzodiazepine at 2 minutes of continuous seizure activity 9
- Administer second-line agent immediately if seizures persist after benzodiazepines—do not wait 2, 10
- Each minute of delay worsens outcomes and increases pharmacoresistance 10, 11
- Status epilepticus is now defined as seizures lasting ≥5 minutes (not 30 minutes) 1
Common pitfall: Waiting too long to escalate therapy. The traditional 30-minute definition of status epilepticus is outdated—treat aggressively at 5 minutes 1, 11.